Lorry Witte ProfileMN ACRP - Lorry Witte Profile
...Lorry Witte, RN, BA, CCRC, CCRAMN ACRP PresidentLorry is currently working as a Clinical Project Manager at AGA Medical Corporation in Plymouth, Minnesota.She
manages the IDE device RESPECT Trial (Randomized Evaluation of Recurrent Stroke comparing PFO (patent foramen ovale) Closure to Established Current Standard of Care Treatment) and a PFO IDE device registry.Previous to her AGA Medical experience, Lorry worked at Medtronic, Inc., for over 7 years managing device studies in the Heart Failure Management and the Cardiac Disease Rhythm Management Pre-Market and Post Market Departments.Lorry started at Medtronic as a Clinical Study Manager in 1999, was promoted to Clinical Research Supervisor in 2003, and to Senior Clinical Trial Leader In 2004.Lorry
was involved in managing a variety of studies (IDE, post-market and registry trials), supervising employees and contractors, writing investigational plans, preparing FDA reports, leading team meetings, writing scientific publications and managing budgets. Prior to Medtronic, Lorry was a Senior Research Nurse Clinician with the University of Minnesota's Research Service Organization.She
also coordinated studies in the University of Minnesota Cardiology Department in heart failure
, peripheral vascular disease, and heart disease prevention.In addition, Lorry worked at Allina Corporation conducting a variety of NIH and company sponsored studies in blood pressure, smoking cessation, weight loss and weight maintenance. Lorry has been a member of the National and MN ACRP since 1998.Over the years, she has served on the chapter's Hospitality, Programming and Sponsorship Committees.She has been a member of the ACRP Device Forum since 1999 and recently joined the Independent Consultant Forum.She
presented at the National ACRP Meeting in April 2005 on the topic, "Billing and Coverage Issues in Device Trials."She
CCRC in 1998 and CCRA in 2002 and also holds State of Minnesota Registered Nurse and Public Health Nurse Certifications.